Chng WJ - Search Results

1

An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphoma.

Goh J, De Mel S, Hoppe MM, Mohd Abdul Rashid MB, Zhang XY, Jaynes P, Ka Yan Ng E, Rahmat NDB, Jayalakshmi, Liu CX, Poon L, Chan E, Lee J, Chee YL, Koh LP, Tan LK, Soh TG, Yuen YC, Loi HY, Ng SB, Goh X, Eu D, Loh S, Ng S, Tan D, Cheah DMZ, Pang WL, Huang D, Ong SY, Nagarajan C, Chan JY, Ha JCH, Khoo LP, Somasundaram N, Tang T, Ong CK, Chng WJ, Lim ST, Chow EK, Jeyasekharan AD. Goh J, et al. Among authors: chng wj. Sci Transl Med. 2022 Oct 19;14(667):eabn7824. doi: 10.1126/scitranslmed.abn7824. Epub 2022 Oct 19. Sci Transl Med. 2022. PMID: 36260690

2

Cyclosporine treatment for patients with CRF who developed pure red blood cell aplasia following EPO therapy.

Chng WJ, Tan LK, Liu TC. Chng WJ, et al. Am J Kidney Dis. 2003 Mar;41(3):692-5. doi: 10.1053/ajkd.2003.50132. Am J Kidney Dis. 2003. PMID: 12612995

3

Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling.

Ng SB, Selvarajan V, Huang G, Zhou J, Feldman AL, Law M, Kwong YL, Shimizu N, Kagami Y, Aozasa K, Salto-Tellez M, Chng WJ. Ng SB, et al. Among authors: chng wj. J Pathol. 2011 Mar;223(4):496-510. doi: 10.1002/path.2823. Epub 2011 Jan 5. J Pathol. 2011. PMID: 21294123

4

Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma.

Ng SB, Yan J, Huang G, Selvarajan V, Tay JL, Lin B, Bi C, Tan J, Kwong YL, Shimizu N, Aozasa K, Chng WJ. Ng SB, et al. Among authors: chng wj. Blood. 2011 Nov 3;118(18):4919-29. doi: 10.1182/blood-2011-07-364224. Epub 2011 Sep 14. Blood. 2011. PMID: 21921041 Free article.

5

The impact of frontline risk-adapted strategy on the overall survival of patients with newly diagnosed multiple myeloma: an analysis of the Singapore multiple myeloma study group.

Tan D, Ong KH, Koh LP, Wong SS, Khin MT, Lee LH, Goh YT, Chng WJ. Tan D, et al. Among authors: chng wj. Eur J Haematol. 2012 Aug;89(2):136-44. doi: 10.1111/j.1600-0609.2012.01797.x. Epub 2012 Jun 21. Eur J Haematol. 2012. PMID: 22553948 Clinical Trial.

6

Type II enteropathy-associated T-cell lymphoma: a multicenter analysis from the Asia Lymphoma Study Group.

Tse E, Gill H, Loong F, Kim SJ, Ng SB, Tang T, Ko YH, Chng WJ, Lim ST, Kim WS, Kwong YL. Tse E, et al. Among authors: chng wj. Am J Hematol. 2012 Jul;87(7):663-8. doi: 10.1002/ajh.23213. Epub 2012 May 28. Am J Hematol. 2012. PMID: 22641357 Free article.

7

Risk factors for adverse outcomes and multidrug-resistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital.

Poon LM, Jin J, Chee YL, Ding Y, Lee YM, Chng WJ, Chai LY, Tan LK, Hsu LY. Poon LM, et al. Among authors: chng wj. Singapore Med J. 2012 Nov;53(11):720-5. Singapore Med J. 2012. PMID: 23192498 Free article.

8

LIN28/LIN28B: an emerging oncogenic driver in cancer stem cells.

Zhou J, Ng SB, Chng WJ. Zhou J, et al. Among authors: chng wj. Int J Biochem Cell Biol. 2013 May;45(5):973-8. doi: 10.1016/j.biocel.2013.02.006. Epub 2013 Feb 16. Int J Biochem Cell Biol. 2013. PMID: 23420006 Review.

9

The impact of upfront versus sequential use of bortezomib among patients with newly diagnosed multiple myeloma (MM): a joint analysis of the Singapore MM Study Group and the Korean MM Working Party for the Asian myeloma network.

Tan D, Kim K, Kim JS, Eom HS, Teoh G, Ong KH, Goh YT, Durie BG, Chng WJ, Lee JH. Tan D, et al. Among authors: chng wj. Leuk Res. 2013 Sep;37(9):1070-6. doi: 10.1016/j.leukres.2013.06.008. Epub 2013 Jun 28. Leuk Res. 2013. PMID: 23816344

10

Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group.

Kim SJ, Hsu C, Song YQ, Tay K, Hong XN, Cao J, Kim JS, Eom HS, Lee JH, Zhu J, Chang KM, Reksodiputro AH, Tan D, Goh YT, Lee J, Intragumtornchai T, Chng WJ, Cheng AL, Lim ST, Suh C, Kwong YL, Kim WS. Kim SJ, et al. Among authors: chng wj. Eur J Cancer. 2013 Nov;49(16):3486-96. doi: 10.1016/j.ejca.2013.07.006. Epub 2013 Aug 1. Eur J Cancer. 2013. PMID: 23910494

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

376 results

Search Page